TY  -  
T1  - In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL 
SN  -  /  
UR  - http://hdl.handle.net/10138/224428 
T3  -  
A1  - Laukkanen, S.; Gronroos, T.; Polonen, P.; Kuusanmaki, H.; Mehtonen, J.; Cloos, J.; Ossenkoppele, G.; Gjertsen, B.; Oystein, B.; Heckman, C.; Heinaniemi, M.; Kontro, M.; Lohi, O. 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - ... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL-ACTIVATION; KINASE INHIBITOR; SENSITIVITY; EXPERIENCE; REMISSION; PATIENT; LCK; 3122 Cancers 
N1  -   
PP  -  
ER  -